NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
29.86
+1.43 (5.03%)
At close: May 4, 2026, 4:00 PM EDT
29.79
-0.07 (-0.23%)
Pre-market: May 5, 2026, 6:25 AM EDT
NAMS Market Cap
NAMS has a market cap or net worth of $3.43 billion as of May 5, 2026. Its market cap has increased by 95.02% in one year.
Market Cap
3.43B
Enterprise Value
2.70B
1-Year Change
95.02%
Ranking
Category
Stock Price
$29.86
Market Cap Chart
Since February 8, 2021, NAMS's market cap has increased from $154.45M to $3.43B, an increase of 2,122.84%. That is a compound annual growth rate of 80.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 3.27B | -17.82% |
| Dec 31, 2025 | 3.98B | 44.58% |
| Dec 31, 2024 | 2.75B | 199.19% |
| Dec 29, 2023 | 919.56M | 3.44% |
| Dec 30, 2022 | 889.00M | 537.58% |
| Dec 31, 2021 | 139.43M | -9.72% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Catalyst Pharmaceuticals | 3.51B |
| Viking Therapeutics | 3.48B |
| Edgewise Therapeutics | 3.29B |
| Kailera Therapeutics | 3.26B |
| Arcus Biosciences | 3.23B |
| Alumis | 3.20B |
| Erasca | 3.12B |
| Beam Therapeutics | 3.08B |